Home โบ Anemia
Anemia clinical trials recruiting in the U.S.
29 studies for Anemia are recruiting participants at sites across the United States.
Anemia occurs when your blood doesn't carry enough oxygen to the rest of your body. Read about conditions that lead to it and treatments available.
Cities with the most studies
- New York City, NY7 studies
- Atlanta, GA6 studies
- Philadelphia, PA6 studies
- Miami, FL6 studies
- Tampa, FL5 studies
- Houston, TX5 studies
- St. Louis, MO4 studies
- Baldwin Park, CA4 studies
- Cleveland, OH4 studies
- Winston-Salem, NC4 studies
- Gilbert, AZ3 studies
- Nashville, TN3 studies
- The Woodlands, TX3 studies
- Portland, OR3 studies
- Los Angeles, CA3 studies
- Seattle, WA3 studies
- Edison, NJ3 studies
- Queens, NY3 studies
- Washington, DC3 studies
- Orlando, FL3 studies
By state
- Arizona4 studies
- California8 studies
- Florida9 studies
- Georgia7 studies
- Maryland3 studies
- Minnesota3 studies
- Missouri6 studies
- New Jersey3 studies
- New York11 studies
- North Carolina5 studies
- Ohio6 studies
- Oregon3 studies
- Pennsylvania7 studies
- Tennessee4 studies
- Texas7 studies
- Washington3 studies
Recently updated studies
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT05320198Study of DISC-0974-201 in Participants With IBD and Anemia
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT07368972A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 18, 2026 ยท NCT07422480A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Aug 24, 2026 ยท NCT07623161A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Aug 21, 2026 ยท NCT06499285A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
RecruitingObservational study
1 Month โ 100 Years ยท All sexes ยท Updated Aug 19, 2026 ยท NCT06092346T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
RecruitingPhase 1/2
Ages 5 to 40 ยท All sexes ยท Updated Aug 13, 2026 ยท NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
RecruitingPhase 3
Ages 2 to 18 ยท All sexes ยท Updated Aug 7, 2026 ยท NCT06934967Choline and Iron Deficiency
RecruitingPhase 2/3
5 Months โ 7 Months ยท All sexes ยท Updated Aug 5, 2026 ยท NCT06527391Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Aug 5, 2026 ยท NCT07224360A Study of Luspatercept in People With Anemia
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Jul 24, 2026 ยท NCT07725497Kids With Iron Deficiency and Scoliosis
RecruitingHealthy volunteers welcome
Ages 10 to 26 ยท All sexes ยท Updated Jun 26, 2026 ยท NCT06042699Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
RecruitingObservational study
Ages 18 to 90 ยท All sexes ยท Updated Jun 17, 2026 ยท NCT06106269131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
RecruitingPhase 1
Ages 12 to 50 ยท All sexes ยท Updated Jun 10, 2026 ยท NCT07015684Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RecruitingPhase 2
3 Days ยท All sexes ยท Updated May 26, 2026 ยท NCT05340465Therapeutic RSK1 Targeting in Myelofibrosis
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated May 22, 2026 ยท NCT07379125Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated May 22, 2026 ยท NCT05800600Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated May 4, 2026 ยท NCT07281781A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
RecruitingPhase 3
Ages 2 to 17 ยท All sexes ยท Updated Apr 17, 2026 ยท NCT03893045Diamond Blackfan Anemia Registry (DBAR)
RecruitingObservational study
All ages ยท All sexes ยท Updated Apr 16, 2026 ยท NCT00106015Luspatercept for Clonal Cytopenias of Uncertain Significance
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Mar 24, 2026 ยท NCT06788691Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease
RecruitingPhase 4Healthy volunteers welcome
Ages 18 and older ยท Women ยท Updated Feb 18, 2026 ยท NCT06979492The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
RecruitingObservational study
Ages 18 to 100 ยท All sexes ยท Updated Feb 6, 2026 ยท NCT06606119129Xe MRI Cardiopulmonary
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Feb 4, 2026 ยท NCT06038630A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Recruiting
Ages 18 and older ยท All sexes ยท Updated Dec 30, 2025 ยท NCT05735314From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.